Medrx Co.,Ltd. Logo

Medrx Co.,Ltd.

Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.

4586 | T

Overview

Corporate Details

ISIN(s):
JP3921220004
LEI:
Country:
Japan
Address:
東かがわ市西山431番地7
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Medrx Co., Ltd., established in 2002, is a pharmaceutical company focused on drug formulation development. The company specializes in creating new dosage forms and value-added medicines, with a core technological expertise in transdermal absorption and drug delivery systems. Medrx conducts research and development to create innovative pharmaceutical candidates, which it then licenses to other companies for final clinical trials, production, and commercialization. The company's primary goal is to improve global health and patient quality of life by developing medications that offer alternatives to conventional oral administration, thereby improving patient adherence and therapeutic effectiveness.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-08 08:33
Interim Report
確認書
Japanese 8.9 KB
2025-08-08 08:31
Interim Report
半期報告書-第24期(2025/01/01-2025/12/31)
Japanese 425.8 KB
2025-06-13 08:31
Share Issue/Capital Change
臨時報告書
Japanese 39.1 KB
2025-03-31 08:33
Governance Information
内部統制報告書-第23期(2024/01/01-2024/12/31)
Japanese 23.9 KB
2025-03-31 08:32
Registration Form
確認書
Japanese 8.7 KB
2025-03-31 08:32
Post-Annual General Meeting Information
臨時報告書
Japanese 25.0 KB
2025-03-31 08:32
Registration Form
訂正有価証券届出書(組込方式)
Japanese 271.6 KB
2025-03-31 08:31
Registration Form
有価証券報告書-第23期(2024/01/01-2024/12/31)
Japanese 1.4 MB
2025-03-28 07:31
Registration Form
訂正有価証券届出書(組込方式)
Japanese 268.0 KB
2025-03-25 07:31
Registration Form
有価証券届出書(組込方式)
Japanese 409.6 KB
2024-08-09 08:01
Interim Report
確認書
Japanese 8.8 KB
2024-08-09 08:00
Interim Report
半期報告書-第23期(2024/01/01-2024/12/31)
Japanese 345.0 KB
2024-05-17 08:01
Share Issue/Capital Change
臨時報告書
Japanese 39.2 KB
2024-05-10 08:02
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-05-10 08:01
Quarterly Report
四半期報告書-第23期第1四半期(2024/01/01-2024/03/31)
Japanese 408.3 KB

Automate Your Workflow. Get a real-time feed of all Medrx Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medrx Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medrx Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

FunPep Company Limited Logo
Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.
Japan
4881
Gain Therapeutics, Inc. Logo
Using an AI platform to develop allosteric therapies for neurodegenerative diseases.
United States of America
GANX
Galaxy Payroll Group Ltd Logo
APAC cross-border payroll, EOR, and corporate services for global businesses.
United States of America
GLXG
GATX CORP Logo
Global lessor of railcars, locomotives, and spare aircraft engines for key industries.
United States of America
GATX
GECOSS CORPORATION Logo
Leases and sells temporary steel materials and equipment for large construction projects.
Japan
9991
GENDAI AGENCY INC. Logo
Advertising agency providing marketing and promotions for the pachinko industry.
Japan
2411
Geneuro Logo
Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.
Switzerland
GEM
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea
095700
GENFLOW BIOSCIENCES PLC Logo
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
United Kingdom
GENF
GENINUS Inc. Logo
AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.
South Korea
389030

Talk to a Data Expert

Have a question? We'll get back to you promptly.